Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying Li has a total of 216 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cerebral Blood Flow-Related Cognitive Impairment Is Mediated by Functional Connectivity in End-Stage Renal Disease Patients Undergoing Hemodialysis CBF–FC Mediation of Cognitive Impairment in Hemodialysis ESRD

    by Wei Sun, Yongqiong Tao, Keying Wang, Yu Wang, Ying Li, Haifeng Shi

    Introduction: Cognitive impairment (CI) is highly prevalent in patients with end-stage renal disease (ESRD) undergoing hemodialysis and is associated with increased morbidity and mortality. Although altered cerebral blood flow (CBF) and disrupted functional connectivity (FC) have been independently reported in ESRD, whether neurovascular alterations mechanistically contribute to CI remains unclear. We aim to investigate whether abnormalities in CBF and FC mediate CI in ESRD patients undergoing hemodialysis. Methods: Patients with ESRD receiving maintenance hemodialysis and matched healthy controls (HCs) underwent arterial spin labeling (ASL) to quantify CBF and resting-state functional magnetic resonance imaging (rs-fMRI) to assess FC. Cognitive performance was evaluated using the adjusted Montreal Cognitive Assessment (MoCA). Between-group differences in regional CBF and whole-brain FC were analyzed. Mediation models were constructed to examine whether altered FC mediated the association between regional CBF and cognitive performance. Results: ESRD patients demonstrated significantly increased standardized CBF (zCBF) predominantly within default mode network (DMN)-related regions compared with HCs. Higher normalized zCBF values in the right posterior cingulate gyrus (PCG.R) and left precuneus were observed in patients with CI and were negatively correlated with MoCA scores. Whole-brain FC analyses revealed decreased connectivity between DMN nodes and limbic structures, particularly reduced connectivity between the PCG.R and left amygdala in the ESRD-CI group. Mediation analysis showed that FC partially mediated the association between regional CBF alterations and MoCA scores, with the FC between the right posterior cingulate gyrus and left amygdala accounting for 35.7% of the total effect. Conclusions: These findings reveal a significant association between altered cerebral hemodynamic patterns, characterized by increased regional zCBF and impaired functional integration within DMN-limbic circuits, and cognitive dysfunction in ESRD patients undergoing hemodialysis. Although the cross-sectional design precludes definitive causal inferences, the observed mediation patterns suggest a potential relationship linking cerebral hemodynamic alterations, functional connectivity changes, and cognitive decline. These findings may guide future longitudinal and interventional investigations to further clarify these relationships.

  • Open Access

    Functional brain abnormalities in patients with somatic symptom disorder presenting with chest pain: a resting-state fMRI study

    by Yi-Fan Ding, Ke-Ying Wang, Ting Yang, Xue-Fei Liu, Ying Li, Hai-Feng Shi, Jin-Wei Qiang

    Somatic symptom disorder (SSD) is characterized by persistent physical symptoms that cannot be fully explained by structural abnormalities or laboratory findings. However, the underlying neural mechanisms of SSD remain poorly understood. This study aimed t o investigate functional brain abnormalities in SSD patients presenting predominantly with chest pain using resting-state functional magnetic resonance imaging (rs-fMRI). A total of 102 participants were prospectively enrolled, including 56 patients with SSD and 46 healthy controls (HCs). All participants underwent clinical assessments and structural MRI examinations, including T2-weighted imaging (T2WI), T1-weighted imaging (T1WI), diffusion-weighted imaging (DWI), fluid-attenuated inversion recovery (FLAIR), and rs-fMRI. The rs-fMRI metrics included regional homogeneity (ReHo), amplitude of low-frequency fluctuations (ALFF), and fractional ALFF (fALFF). Group comparisons were conducted to identify differences in brain activity, and correlation analyses were performed to examine associations between brain activity and clinical symptoms. No significant differences were observed between the two groups in demographic variables, including age, gender, and education level. Clinical assessments revealed that SSD patients scored significantly higher than HCs on the Patient Health Questionnaire-15 (PHQ-15), Somatic Symptom Scale (SSS), Generalized Anxiety Disorder-7 (GAD-7), and Hamilton Depression Scale (HAMD). ALFF, fALFF, and ReHo analyses demonstrated significant alterations in spontaneous neural activity in SSD patients compared with HCs. Specifically, increased activity was observed in the left inferior frontal gyrus and precuneus, whereas decreased activity was detected in the hippocampus and insula. Correlation analyses revealed significant associations between these abnormal brain activity patterns and clinical symptom severity in SSD patients. This study highlights regional functional brain abnormalities in SSD, particularly in regions associated with emotion regulation, memory, and sensory processing. These findings provide novel insights into the neural mechanisms underlying SSD and suggest potential neuroimaging targets for therapeutic interventions that may help alleviate symptoms and improve patient outcomes.


  • Open Access

    Multimodal neuroimaging of locus coeruleus-default mode network connectivity for predicting dexmedetomidine response in chronic insomnia disorder

    by Yongqiong Tao, Yonghong Zhou, Yongtao Tang, Zhouquan Wu, Ying Li, Haifeng Shi

    Objectives: To explore whether pre-treatment functional connectivity between the locus coeruleus (LC) and default mode network (DMN), nodal graph-theoretical features, and gray matter volume can identify chronic insomnia patients who respond poorly to dexmedetomidine patient-controlled sleep therapy (PCSL). Methods: Chronic insomnia patients underwent PCSL with sub-anesthetic dexmedetomidine and were classified as responders or non-responders based on changes in the Pittsburgh Sleep Quality Index. All patients and matched good sleeper received pre-treatment resting-state functional Magnetic Resonance Imaging (MRI) and structural MRI. Functional connectivity, graph metrics, and gray matter volumes of LC and DMN regions were extracted. Predictors were selected using univariate analysis and Least Absolute Shrinkage and Selection Operator regression (LASSO), then used in a multivariate logistic model. Model performance was assessed via Receiver Operating Characteristic (ROC), calibration, decision curve analysis, and bootstrap validation. Results: No gray matter volume differences were found between responders and non-responders except increased right hippocampal volume in non-responders versus controls. Non-responders showed widespread increased LC-DMN connectivity pre-treatment, especially between right LC and left lateral temporal cortex versus responders. Graph metrics of key nodes (temporoparietal junction, lateral temporal cortex) were significantly reduced in non-responders. Three imaging features were included in the model, achieving an AUC of 0.816 with good calibration and clinical utility. Conclusion: Pre-treatment LC-DMN functional and network topology differences may underlie variable responses to dexmedetomidine PCSL in chronic insomnia. The multimodal imaging model effectively predicts treatment sensitivity and may guide personalized interventions.

  • Open Access

    The role of quantitative T1 and T2 mapping for detecting minimal hepatic encephalopathy in chronic hepatic schistosomiasis patients

    by Xue-Fei Liu, Ke-Ying Wang, Hai-Feng Shi, Ying Li, Xin Li

    Background: Minimal hepatic encephalopathy (MHE) is a frequent neurocognitive complication in chronic hepatic schistosomiasis (CHS) patients. Conventional diagnostic tools are time-consuming and influenced by education level. Quantitative MRI mapping offers a potential non-invasive biomarker for MHE, but its role in CHS remains unclear. Aim: This study aimed to evaluate the diagnostic value of quantitative T1 and T2 mapping for detecting MHE in CHS patients. Methods: This prospective cross-sectional observational study was conducted from August 2023 to July 2024. A total of 88 CHS patients were enrolled and divided into MHE (n = 50) and non-MHE group (n = 38). MHE was assessed using the number connection test-A (NCT-A) and digit symbol test (DST). All participants underwent 3.0T MRI with T1 and T2 mapping. Group comparisons, correlation analyses, logistic regression, and receiver operating characteristic (ROC) curve analyses were performed. Results: MHE patients exhibited significantly lower T1 values across multiple brain regions, particularly the globus pallidus (all p < 0.001). T2 values showed no significant differences between groups. Multivariable regression confirmed that lower T1 values were independently associated with MHE (p = 0.009). ROC analysis demonstrated excellent diagnostic performance of globus pallidus T1 values (AUC = 0.92, 95% CI: 0.86–0.99), with sensitivity of 0.97 and specificity of 0.90. T1 values were also correlated with neuropsychological tests (NCT-A: r = −0.345, p < 0.001; DST: r = 0.232, p = 0.029). However, T2 values showed no significant group differences or diagnostic value. Conclusion: Quantitative T1 mapping, rather than T2 mapping, could be used as a potential non-invasive biomarker for detecting MHE in CHS patients. This approach offers an objective complement to psychometric testing and may facilitate earlier diagnosis and monitoring of MHE progression.

  • Open Access

    Portal vein hemodynamics measured by 4D flow MRI in predicting minimal hepatic encephalopathy in chronic hepatic schistosomiasis patients

    by Xue-Fei Liu, Ke-Ying Wang, Hai-Feng Shi, Ying Li, Xin Li

    Background: Minimal hepatic encephalopathy (MHE) is a subclinical neuropsychological disorder frequently observed in chronic hepatic schistosomiasis (CHS) patients. Early diagnosis is challenging due to the subtle and nonspecific nature of MHE symptoms. Advances in magnetic resonance imaging (MRI), specifically 4D flow MRI, allow for non-invasive evaluation of portal vein hemodynamic parameters, offering a potential tool for diagnosing MHE.Objective: To evaluate the application of portal vein hemodynamic parameters measured by 4D flow MRI in diagnosing MHE in CHS patients.Methods: This prospective observational study included 118 CHS patients, divided into MHE (n = 52) and non-MHE (n = 66) groups. Portal vein hemodynamic parameters, including peak velocity, mean velocity, flow volume, and vessel area, were measured using 4D flow MRI. Correlation analyses were used to assess the relationship between these parameters and MHE. Diagnostic performances of portal vein hemodynamic parameters in MHE were also evaluated.Results: Patients with MHE exhibited significantly lower portal peak velocity (p < 0.001) and mean velocity (p < 0.001). Portal area (p < 0.001) was higher in MHE patients. Correlation analysis revealed significant associations between MHE and portal peak velocity (r = −0.389), mean velocity (r = −0.566), and area (r = 0.435). The diagnostic performance of portal peak velocity, mean velocity, and area in MHE demonstrated AUC of 0.70 (95% CI: 0.61–0.79) with specificity, sensitivity, negative predictive value (NPV) and positive predictive value (PPV) of 0.92, 0.47, 0.58, and 0.89, respectively; AUC of 0.82 (95% CI: 0.74–0.89) with specificity, sensitivity, NPV and PPV of 0.98, 0.64, 0.68, and 0.98, respectively; AUC of 0.74 (95% CI: 0.65–0.83) with specificity, sensitivity, NPV and PPV of 0.94, 0.46, 0.69, and 0.86, respectively.Conclusion: 4D flow MRI-derived portal vein hemodynamic parameters, particularly portal mean velocity, are significantly associated with MHE in CHS patients. These findings suggest that non-invasive imaging can provide insights for diagnosis and management of MHE, potentially improving clinical outcomes.

  • Open Access

    Ovarian lipid metabolic alterations in polycystic ovary syndrome: insights from proton magnetic resonance spectroscopy

    by Ke-Ying Wang, Ting Yang, Yi-Fan Ding, An-Rong Zeng, Ying Li, Jin-Wei Qiang

    Objectives: Altered ovarian lipid metabolism plays a critical role in the pathophysiology of polycystic ovary syndrome (PCOS). This study aimed to evaluate and compare ovarian lipid metabolic profiles in PCOS patients and healthy controls using proton magnetic resonance spectroscopy (1H-MRS).Method: This was a single-center prospective study. Single-voxel 1H-MRS was used to identify the lipid metabolism in 50 PCOS patients and 40 healthy controls (training cohort). A total of 34 PCOS patients and 39 controls underwent 1H-MRS on the contralateral ovaries (test cohort). Key lipid metabolites were identified and quantified using LCModel software. A combination of these key lipids using the binary logistic regression analysis was constructed to enhance the discrimination efficiency between PCOS patients and the controls.Results: Significant elevations were observed in lipid metabolites MM09 + Lip09, MM14 + Lip13a + Lip13b + MM12, MM21 + Lip21, Lip23, and Lip28 (e.g., MM09, macromolecule signal at 0.9 ppm; Lip09, lipid signal at 0.9 ppm) in PCOS patients compared to controls. The combination model of key lipids achieved an AUC of 0.89 [95% confidence interval (CI): 0.83–0.95], with sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 0.76, 0.95, 0.95, and 0.76, respectively, in the training cohort, and 0.88 (95% CI, 0.80–0.95), 0.76, 0.87, 0.84, and 0.81, respectively, in the test cohort. Pathway enrichment analysis revealed significant involvement of fatty acid metabolism, phospholipid synthesis, lipid signaling, and membrane organization pathways.Conclusion: The study highlights significant lipid metabolic disruptions in PCOS. Lip23 and Lip28 emerged as potential biomarkers for PCOS diagnosis. These findings enhance the understanding of PCOS pathophysiology and provide a foundation for future targeted therapeutic approaches.


  • Open Access

    CT-based radiomics nomogram for differentiating dedifferentiated liposarcoma from well-differentiated liposarcoma

    by Ting Yang, Ruo-Yu Chen, Yi-Fan Ding, Jing-Yan Wu, Ying Li, Jin-Wei Qiang

    Purpose: This study aimed to use radiomics features derived from plain CT scans to construct a model that can predict the pathological classification of Retroperitoneal liposarcoma (RLPS) preoperatively, help enhance preoperative planning and inform tailored treatment strategies.Methods: This retrospective study involving 114 consecutive RLPS patients from January 2022 to December 2024. Clinical, pathological, and CT imaging data were gathered. Radiomics features were extracted from plain CT scans and were selected through Least Absolute Shrinkage and Selection Operator (LASSO) regression. A radiomics signature was created, and a nomogram was developed for predicting dedifferentiated liposarcoma (DDLPS). Performance of the nomogram was assessed and compared with radiologist evaluation of the CT imaging. Area under the curve (AUC) and decision curve analysis in both training and validation sets.Results: Higher Ki-67 and unclear tumor boundary was established as an independent predictor for DDLPS. Five radiomics features were identified as significant predictors. a nomogram was developed by combining these features. The nomogram showed an AUC of 0.91 (95% CI: 0.84-0.98) and 0.89 (95% CI: 0.73-1.00) in the training and validation set, which outperforming the radiologist evaluation. Decision curve analysis confirmed that the nomogram provided a higher net clinical benefit compared to the radiologist.Conclusions: The radiomics nomogram significantly enhances the preoperative differentiation of RLPS subtypes.


  • Open Access

    Multi-parametric MRI-based radiomics nomogram for predicting lymphovascular space invasion in early-stage cervical adenocarcinoma

    by Ke-Ying Wang, Mei-Ling Xiao, Yu-Han Fang, Jie-Jun Cheng, Zi-Jing Lin, Ying Li, Jin-Wei Qiang

    Purpose: To develop a magnetic resonance imaging (MRI)-based radiomics nomogram to predict lymphovascular space invasion (LVSI) status in patients with early-stage cervical adenocarcinoma (CAC).Methods: Clinicopathological and MRI data from 310 patients with histopathologically confirmed early-stage CAC were retrospectively analyzed. Patients were divided into training (n = 186) and validation (n = 124) cohorts. Tumor volumes of interest (VOIs) were segmented on T2-weighted imaging (FS-T2WI) and aligned to diffusion-weighted imaging (DWI), apparent diffusion coefficient (ADC) maps, and T1-weighted imaging (CE-T1WI) sequences. Radiomics features were extracted and screened using Pearson correlation and least absolute shrinkage and selection operator (LASSO) regression, and a radscore was calculated for each patient. Multivariate logistic regression identified clinical risk factors, and a radiomics nomogram was constructed by integrating the radscore with clinical risk factors. Receiver operating characteristic (ROC) curves and areas under the curve (AUCs) were used to evaluate the performance of the clinical model, radiomics model, and nomogram. Decision curve analysis was used to assesses the clinical utility of the nomogram.Results: Seventeen radiomics features were selected to construct the radscore. Menopause and tumor diameter were identified as independent clinical risk factors for LVSI. The radiomics nomogram achieved AUCs of 0.80 (95% CI: 0.74-0.86) and 0.78 (95% CI: 0.69-0.86) in the training and validation cohorts, outperforming the clinical model (AUCs: 0.69 and 0.62) and comparable to the radiomics model (AUCs: 0.79 and 0.78). Decision curve analysis showed the nomogram provided clinical benefit.Conclusions: The radiomics nomogram, integrating radiomic features and clinical risk factors, could be used to predict LVSI status in early-stage CAC accurately, supporting preoperative clinical decision-making.


  • Open Access

    Application of intravoxel incoherent motion imaging in the diagnosis of polycystic ovary syndrome

    by Keying Wang, Qian Song, Anrong Zeng, Ying Li, Jinwei Qiang

    Objective: To evaluate the diagnostic efficacy of intravoxel incoherent motion (IVIM) parameters in ovarian stroma changes in polycystic ovary syndrome (PCOS) patients.Methods: This prospective study included 58 PCOS patients and 60 healthy controls. Both groups underwent conventional magnetic resonance imaging (MRI) and IVIM scans. The diagnostic efficacy of IVIM parameters and conventional MRI was investigated and compared by using area under the curves (AUC). Binary logistic regression analysis, integrated discrimination improvement (IDI), and net reclassification improvement (NRI) were also used to assess the improvement in diagnosis of PCOS when combining IVIM parameters with conventional MRI features.Results: The apparent diffusion coefficient (ADC) and D values were significantly lower, while the D* and f values were significantly higher than the controls in the ovarian stroma in PCOS patients. The follicle number (FN) counted on the MRI showed an AUC of 0.90 (95%CI: 0.84–0.96) for differentiating PCOS from the controls, with a cutoff value of 23. The ADC value yielded the highest AUC of 0.83 (95%CI: 0.76–0.90) among the IVIM parameters, with a cutoff value of 1.04 × 10−3 mm2/s. The diagnostic performance was significantly by combining ADC and FN with an AUC of 0.94 (95%CI: 0.90–0.98). The IDI and NRI also showed improved diagnostic performance than FN alone.Conclusion: The D* and f values of the ovarian stroma in PCOS patients are significantly increased, while the ADC and D values are significantly reduced. The combination of ADC and FN can improve the diagnostic efficacy for PCOS.

  • Three-dimensional MRI follicle segmentation and counting using SegmentWithSAM in the diagnosis of polycystic ovary syndrome

    by Anrong Zeng, Jing Lu, Ying Li

    Objective This study aimed to investigate the diagnostic performance of Follicle numbers measured on ultrasound (US), conventional magnetic resonance imaging (2D MRI), and three-dimensional (3D) MRI in patients with polycystic ovary syndrome (PCOS) and to compare the diagnostic efficacy of these imaging modalities. Method In this prospective study, 58 PCOS patients and 60 healthy women underwent US, conventional 2D MRI, and 3D MRI. Clinical laboratory tests and ovarian volume were compared between PCOS and control groups. Follicle numbers measured on US (FN-US), 2D MRI (FN-2D), and 3D MRI (FN-3D) using SegmentWithSAM were compared between PCOS and control groups using receiver operating characteristic (ROC) curve analysis and the DeLong test. Results Ovarian volume and follicle numbers were significantly higher in the PCOS group than in the control group. The diagnostic performance was found with FN-3D achieving the highest AUC of 0.94 (95% CI: 0.90–0.98), superior to that of US (0.80 [95% CI: 0.72–0.88]) and 2D MRI (0.90 [95% CI: 0.84–0.96]), respectively. Significant differences in the diagnostic efficacy of follicle counts were observed between US, conventional MRI, and 3D MRI, with 3D MRI showing superior results. Conclusion 3D MRI was superior to US and 2D MRI in diagnosing PCOS, with the ability to display small follicles. Graphical abstract